CN102247552A - Kudzuvine root and cinnamomvine capsules for cardiovascular and cerebrovascular diseases - Google Patents
Kudzuvine root and cinnamomvine capsules for cardiovascular and cerebrovascular diseases Download PDFInfo
- Publication number
- CN102247552A CN102247552A CN2011102278145A CN201110227814A CN102247552A CN 102247552 A CN102247552 A CN 102247552A CN 2011102278145 A CN2011102278145 A CN 2011102278145A CN 201110227814 A CN201110227814 A CN 201110227814A CN 102247552 A CN102247552 A CN 102247552A
- Authority
- CN
- China
- Prior art keywords
- cardiovascular
- medicine
- root
- capsules
- cinnamomvine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses kudzuvine root and cinnamomvine capsules for cardiovascular and cerebrovascular diseases, and belongs to the field of Chinese medicines. The capsules consist of the following components: incised notopterygium rhizome, astragalus, root of red-rooted salvia, Szechuan lovage rhizome, American ginseng, leech, rosewood heart wood, earthworm, kudzuvine root, Chinese caterpillar fungus, Chinese magnoliavine fruit, oriental waterplantain rhizome, suberect spatholobus stem, bamboo shavings, platycladi seed, cassia twig, Chinese angelica, gambir plant, chrysanthemum, pericarpium trichosanthis, Chinese taxillus twig, centipede, eucommia bark, chaff flower root, white paeony root, cinnamomvine, grassleaf sweelflag rhizome and liquoric root. The kudzuvine root and cinnamomvine capsules improve cerebral anoxia, reduce hypertension, hyperlipaemia and high cholesterol, have the curative effect on cerebral thrombosis, coronary disease, cardiovascular and cerebrovascular sclerosis, insomnia, dreaminess, memory loss, listlessness and aching and limp in lower limbs which are caused by the hypertension, the hyperlipaemia and the high cholesterol, and have the good effect on patients who suffer from the cardiovascular and cerebrovascular diseases and cerebral infarction for half a year. The effective rate is 92 percent, and the cure rate is 85 percent.
Description
Technical field
The present invention relates to cardiovascular and cerebrovascular vessel Radix Puerariae Rhizoma Dioscoreae capsule, belong to the field of Chinese medicines, particularly treat the Chinese medicine of cardiovascular and cerebrovascular disease.
Background technology
Cardiovascular and cerebrovascular disease is a mortality rate, and the pertinacious disease that disability rate is higher makes people bear the big fear of generation and painful.The cholic acid compounds of treatment hyperlipidemia on the market, the fibrate drug blood fat reducing is very fast, but side effect clearly, take for a long time and can cause hepatic lesions, the nitrate esters of treatment coronary heart disease, angina pectoris, myocardial infarction, calcium antagonist, receptor blocking agent and antiplatelet drug all have very big side effect.With the quickening pace of modern life, the prevalence of cardiovascular and cerebrovascular disease, sickness rate, mortality rate rise year by year, and human beings'health and life in serious threat.
Summary of the invention
The present invention is directed to above-mentioned problems of the prior art, according to causing the reason of cardiovascular and cerebrovascular disease, multiple therapy methods such as adopt boosting qi and nourishing yin, blood circulation promoting and blood stasis dispelling, inducing resuscitation and resolving phlegm, tranquilizing by nourishing the heart, relieve dizziness, high fever, infantile convulsions, epilepsy, etc. makes each the Xingqi duty of patient's self-recovery function, treating both the principal and secondary aspects of a disease, the control combination, good effect, cure rate height, effective percentage 95%, cure rate 85% does not rebound after the drug withdrawal, a kind of Chinese medicinal capsule that has no side effect.
The present invention is achieved through the following technical solutions:
The best proportioning of Chinese medicine of the present invention is:
The manufacture method of medicine of the present invention, instructions of taking:
With each flavor Chinese medicine roguing respectively, drying, be ground into superfine end with pulverizer then earlier, cross 100 mesh sieves, standby.With fashionable dress 0
#Capsule, every capsules pastille 0.3g.Every day 2 times when taking, each 6, taking medicine after meal, is stayed up late at period in a medicine ban on opium-smoking and the opium trade wine, and fasting is with Radix Raphani, Aqua Folium Camelliae sinensis and fatty high food.
The taboo of medicine of the present invention: period in a medicine ban on opium-smoking and the opium trade wine, stay up late, fasting is with Radix Raphani, Aqua Folium Camelliae sinensis and fatty high food.Acute cerebral hemorrhage patient and allergic constitution person forbidding.
Pharmacological action: Rhizoma Et Radix Notopterygii, have wind-damp dispelling, the effect of sharp joint, the exterior cold of loosing is controlled headache, stiffness of the nape muscular contracture; The Radix Astragali, the processed with honey invigorating the spleen and replenishing QI strengthens autoimmunity, controls diseases such as spontaneous perspiration, arthralgia due to stagnation of blood; Radix Salviae Miltiorrhizae, blood circulation promoting and blood stasis dispelling, calming heart and tranquilizing mind, angina pectoris is controlled in the evacuation of pus pain relieving, diseases such as palpitation with fear sleeplessness; Rhizoma Chuanxiong has the activating QI to alleviate the depression dispeiling pathogenic wind and removing dampness, the effect of promoting blood circulation and stopping pain; Radix Panacis Quinquefolii, lung benefiting the moon, clear asthenic fire, promoting the production of body fluid to quench thirst; Hirudo has removing blood stasis, the effect of the meridian dredging; Lignum Dalbergiae Odoriferae, have regulate the flow of vital energy, the effect of hemostasis, clots absorbing analgesic therapy; Pheretima, the heat clearing away suppressing the hyperactive liver, removing obstruction in the collateral to relieve pain is controlled arthralgia, convulsion with spasms, wind heat brains, hemiplegia; Radix Puerariae; Cure mainly hypertension and increase brain and blood flow coronarius; Cordyceps, it is multiple to cure mainly after being ill prolonged deficiency; Fructus Schisandrae Chinensis is mended former QI-insufficiency; Rhizoma Alismatis, promoting diuresis to eliminate damp pathogen, heat clearing away tonifying YIN, this medicine blood fat reducing; Caulis Spatholobi, relaxing muscles and tendons to promote blood circulation is controlled soreness of waist and knee joint, paralysis and numbness, blood stasis dispelling blood tissue regeneration promoting blood, fluent passages through which vital energy circulates is controlled wind arthralgia due to stagnation of blood disease; Caulis Bambusae In Taenia has the clearing away heat and cooling blood clears phlegm; Semen Platycladi, the gas that nourishes heart, the profit kidney is dry, and Fructus Alpiniae Oxyphyllae is allayed excitement, and cures mainly: deficiency of heart-blood, absentminded; Ramulus Cinnamomi, the meridian dredging, the effect of pain relieving is the key medicine of part of the body cavity above the diaphragm housing the heart and lungs tying-in; Radix Angelicae Sinensis, the tonify deficiency that nourishes blood, enriches blood, invigorates blood circulation is thin; Ramulus Uncariae Cum Uncis, suppressing the hyperactive liver relieves dizziness, high fever, infantile convulsions, epilepsy, etc.; Flos Chrysanthemi, dispelling wind reduces phlegm and internal heat, and cures mainly headache due to pathogenic wind-heat, and is dizzy; The fruit-rind of Chinese trichosanthes, clearing away phlegm is controlled chest pain, the effect of promoting the circulation of QI the chest stuffiness relieving; Herba Taxilli, the Cortex Eucommiae, two flavor invigorating liver and kidneys, bone and muscle strengthening, the effect of blood pressure lowering; Scolopendra goes the wind and removing obstruction in channels pain relieving; Radix Achyranthis Bidentatae, strong waist knee joint, bone and muscle strengthening, blood pressure lowering is part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels guiding drug; The Radix Paeoniae Alba, the effect of blood-supplementing blood-nourishing easing the affected liver; Rhizoma dioscoreae (parched), spleen invigorating QI invigorating benefit meat; Rhizoma Acori Graminei, the effect of the eliminating phlegm of having one's ideas straightened out, the diffusing wind of vital energy regualting and blood circulation-promoting; Radix Glycyrrhizae (processed with honey), invigorating the spleen and replenishing QI, coordinating the actions of various ingredients in a prescription.
The characteristics of medicine of the present invention: 1. quick blood stasis dispelling, improve the brain anoxia, antihypertensive, hyperlipidemia, hypercholesterolemia.To cerebral thrombosis, coronary heart disease, the cerebrovascular sclerosis that hypertension, hyperlipidemia, hypercholesterolemia cause, the insomnia and dreamful sleep that causes, forgetful lethargy, lower limb are aching and limp, and this medicine is imitated cardiovascular and cerebrovascular vessel, cerebral infarction early stage half a year of above patient's effect.2. manufacture method of the present invention is simple, and taking convenience is portable.3. drug price of the present invention is cheap.
The specific embodiment
Embodiment 1:
The manufacture method of medicine of the present invention, instructions of taking:
With each flavor Chinese medicine roguing respectively, drying, be ground into superfine end with pulverizer then earlier, cross 100 mesh sieves, standby.With fashionable dress 0
#Capsule, every capsules pastille 0.3g.Every day 2 times when taking, each 6, taking medicine after meal, is stayed up late at period in a medicine ban on opium-smoking and the opium trade wine, and fasting is with Radix Raphani, Aqua Folium Camelliae sinensis and fatty high food.
The taboo of medicine of the present invention:
Period in a medicine ban on opium-smoking and the opium trade wine, stay up late, fasting is with Radix Raphani, Aqua Folium Camelliae sinensis and fatty high food.Acute cerebral hemorrhage patient and allergic constitution person forbidding.
Clinical data:
The inventor carries out clinical observation treatment to 300 routine cardiovascular and cerebrovascular disease patients, male's 120 examples wherein, women's 180 examples, age 45-75 year.
Efficacy assessment standard:
The present invention is mainly used in the treatment cardiovascular and cerebrovascular disease, with doing well,improving situation and every detection data, as the treatment standard.
1. clinical cure: symptom all disappears, and main physics and chemistry detects index and is normally;
2. produce effects: symptomatology is eliminated or most of the elimination, and it is normal substantially that physics and chemistry detects index;
3. effective: cardinal symptom disappears substantially, and main physics and chemistry detects index and makes moderate progress;
4. invalid: as to detect the index no change before and after the treatment.
Clinical efficacy: 2 months was 1 course of treatment, and cure general patient 2-3 the course of treatment, and the patient with severe symptoms cures 4 courses of treatment.
Therapeutic outcome: clinical cure 255 examples, invalid 24 examples, produce effects 9 examples, effective 12 examples, total effective rate 92%, cure rate 85%.
Case 1: appoint XX, man, 72 years old, Zhecheng County, Henan Province appoints Zhuan Cunren in the Liang Zhuan township, comes my specific treatment on April 8th, 2009, main suit's headache, dizziness, slurred speech, dysphagia, the upper and lower extremities dysfunction, slobbering, crying, it is unusual to laugh at, CT shows the long-pending point-like infraction of brain large tracts of land, patient took medicine the same day, and after three days, symptom is alleviated to some extent, continue and obey 1 course of treatment (2 months), it is normal that patient's above-mentioned symptom recovers substantially.
Case 2: Feng, the man, 58 years old, Anping people from town, Zhecheng County, Henan Province, December was gone to a doctor on the 3rd in 2008.Suffer from coronary heart disease heart strand, once hospitalization repeatedly.Over nearly two months, because of every overstrain is promptly felt chest distress, pareordia dull pain, dizziness, cardiopalmus is nervous, and is weak uncomfortable in chest, has an electro-cardiogram in city hospital and show: chronic coronary artery blood supply insufficiency.Through taking coronary dilating medicines such as sorbitrate, persantin, FUFANG DANSHEN PIAN, the difficult eventually control of symptom.Go to a doctor with coming here.Take course of treatment of this medicine, uncomfortable in chest pained big slow, the patient serve on this medicine transference cure 2 course of treatment altogether with requiring to obey one course of treatment of medicine-feeding again, and the electrocardiogram prompting: the coronary artery blood supply is normal.
Claims (3)
3. according to claim 1 or the capsular manufacture method of 2 described cardiovascular and cerebrovascular vessel Radix Puerariae Rhizoma Dioscoreaes, it is characterized in that: with each flavor Chinese medicine roguing respectively, drying, be ground into superfine end with pulverizer then earlier, cross 100 mesh sieves, standby.With fashionable dress 0
#Capsule, every capsules pastille 0.3g.Every day 2 times when taking, each 6, taking medicine after meal, is stayed up late at period in a medicine ban on opium-smoking and the opium trade wine, and fasting is with Radix Raphani, Aqua Folium Camelliae sinensis and fatty high food.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102278145A CN102247552A (en) | 2011-08-10 | 2011-08-10 | Kudzuvine root and cinnamomvine capsules for cardiovascular and cerebrovascular diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102278145A CN102247552A (en) | 2011-08-10 | 2011-08-10 | Kudzuvine root and cinnamomvine capsules for cardiovascular and cerebrovascular diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102247552A true CN102247552A (en) | 2011-11-23 |
Family
ID=44975356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011102278145A Pending CN102247552A (en) | 2011-08-10 | 2011-08-10 | Kudzuvine root and cinnamomvine capsules for cardiovascular and cerebrovascular diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102247552A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102742691A (en) * | 2012-07-24 | 2012-10-24 | 刘建生 | Health-care tea drink with blood pressure lowering effect and preparation method thereof |
CN103110693A (en) * | 2013-02-06 | 2013-05-22 | 长沙理工大学 | Composition for preventing, treating or assisting in treating cardiovascular and cerebrovascular diseases or chronic diseases, and preparation method and application thereof |
CN103520568A (en) * | 2013-10-08 | 2014-01-22 | 谭钦文 | Traditional Chinese medicine for treating qi stagnation and blood stasis symptom type chest impediment |
CN104667202A (en) * | 2015-03-30 | 2015-06-03 | 庄绪娜 | Traditional Chinese medicine composition for treating hypertension |
CN105832776A (en) * | 2016-04-18 | 2016-08-10 | 林日盈 | Antihypertensive migu (Chinese character) tea of traditional Chinese medicine |
-
2011
- 2011-08-10 CN CN2011102278145A patent/CN102247552A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102742691A (en) * | 2012-07-24 | 2012-10-24 | 刘建生 | Health-care tea drink with blood pressure lowering effect and preparation method thereof |
CN103110693A (en) * | 2013-02-06 | 2013-05-22 | 长沙理工大学 | Composition for preventing, treating or assisting in treating cardiovascular and cerebrovascular diseases or chronic diseases, and preparation method and application thereof |
CN103110693B (en) * | 2013-02-06 | 2015-01-21 | 长沙理工大学 | Composition for preventing, treating or assisting in treating cardiovascular and cerebrovascular diseases or chronic diseases, and preparation method and application thereof |
CN103520568A (en) * | 2013-10-08 | 2014-01-22 | 谭钦文 | Traditional Chinese medicine for treating qi stagnation and blood stasis symptom type chest impediment |
CN104667202A (en) * | 2015-03-30 | 2015-06-03 | 庄绪娜 | Traditional Chinese medicine composition for treating hypertension |
CN104667202B (en) * | 2015-03-30 | 2018-06-15 | 党广旺 | A kind of Chinese medicine composition for treating hypertension |
CN105832776A (en) * | 2016-04-18 | 2016-08-10 | 林日盈 | Antihypertensive migu (Chinese character) tea of traditional Chinese medicine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105031088A (en) | Foot bathing powder for treating rheumatoid arthritis and preparation method thereof | |
CN105561214A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
CN103386016B (en) | Blood circulation-promoting and collateral-activating pill | |
CN102247552A (en) | Kudzuvine root and cinnamomvine capsules for cardiovascular and cerebrovascular diseases | |
CN103877194A (en) | Traditional Chinese medicine for treating stroke | |
CN105031213A (en) | Traditional Chine medicine foot bathing powder for treating arthritis and preparation method thereof | |
CN102698092A (en) | Traditional Chinese medicine composition for treating liver-Yang hyperactivity-type hypertension | |
CN103316141A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
CN100512852C (en) | Composite Chinese medicine took orally for treating coronary heart disease | |
CN102670995A (en) | Group of pure traditional Chinese medicinal formula for treating cardiovascular and cerebrovascular diseases and preparation method of same | |
CN101601767B (en) | Traditional Chinese medicine lotion for treating calcanodynia | |
CN106110216A (en) | Treat neurasthenic Chinese medicinal formulae | |
CN100512840C (en) | Chinese medicine for treating hypertension, diabetes and coronary heart disease caused by atherosclerosis | |
CN103301328B (en) | Trigeminal neuralgia treatment medicine | |
CN102512519A (en) | Medicinal moxa roll for treating osteoporosis and preparation method thereof | |
CN103041271B (en) | Traditional Chinese medicine composition for treating emphysema | |
CN102836338A (en) | Chinese medicament for treating cardia-cerebrovascular diseases | |
CN102988860B (en) | Traditional Chinese medicine composition for treating vertigo | |
CN102579799A (en) | Traditional Chinese medicine composition for treating postpartum fever with blood deficiency | |
CN103212039B (en) | Traditional Chinese medicine composition for treating infantile cough caused by qi deficiency | |
CN105878775A (en) | Medicine for treating cardiovascular diseases | |
CN105055919A (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
CN104547916A (en) | Traditional Chinese medicine decoction for treating coronary heart disease | |
CN109758538A (en) | A kind of Chinese medicine preparation and preparation method thereof for treating apoplexy sequelae | |
CN103463463A (en) | Traditional Chinese medicine preparation for replenishing and activating blood and dispelling wind and removing dampness |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20111123 |